Sagimet Biosciences (SGMT) Share-based Compensation (2022 - 2026)

Sagimet Biosciences' Share-based Compensation history runs 5 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 24.93% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 13.58% YoY), while the FY2025 annual figure was $6.4 million, up 21.96% from the prior year.
• Share-based Compensation was $1.8 million for Q1 2026 at Sagimet Biosciences, up from $1.7 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.9 million in Q3 2023 to a low of $383000.0 in Q2 2022.
• Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation jumped 376.86% in 2023, then fell 16.66% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $721000.0 in 2022, then surged by 81.83% to $1.3 million in 2023, then grew by 17.01% to $1.5 million in 2024, then rose by 10.23% to $1.7 million in 2025, then grew by 8.75% to $1.8 million in 2026.
• The last three Share-based Compensation figures came in at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.